Oculis Holding AG (OCS) Divestments (2023 - 2026)
Oculis Holding AG's (OCS) quarterly Divestments came in at -$32.6 million in Q1 2026, up 43.12% year-on-year from -$22.8 million in Q1 2025, and up 20.15% quarter-over-quarter from -$40.8 million in Q4 2025.
Oculis Holding AG (OCS) Divestments (2023 - 2026) Analysis & Trends
Oculis Holding AG's Divestments history runs 4 years deep, the most recent figure standing at -$32.6 million for Q1 2026.
- On a quarterly basis, Divestments rose 43.12% year-over-year to -$32.6 million in Q1 2026; TTM through Mar 2026 was -$45.5 million, a 37.86% increase from a year earlier, with the FY2025 full-year figure at -$73.5 million, down 302.01% from the prior year.
- Divestments climbed to -$32.6 million in Q1 2026 per OCS's latest filing, from -$40.8 million in the prior quarter.
- Across five years, Divestments topped out at $31.1 million in Q2 2025 and bottomed at -$57.3 million in Q1 2025.
- The 4-year median for Divestments is -$3.2 million (2025), against an average of -$9.0 million.
- Biggest YoY gain for Divestments was 253.72% in 2025; the steepest drop was 4280.86% in 2025.
- Year by year, Divestments stood at $25.9 million in 2023, then slumped by 103.6% to -$931481.8 in 2024, then sank by 4280.86% to -$40.8 million in 2025, then increased by 20.15% to -$32.6 million in 2026.
- Per Business Quant, the three latest OCS Divestments figures stand at -$32.6 million (Q1 2026), -$40.8 million (Q4 2025), and -$3.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.58 Mn |
| Dec 31, 2025 | -40.81 Mn |
| Sep 30, 2025 | -3.24 Mn |
| Jun 30, 2025 | 31.14 Mn |
| Mar 31, 2025 | -57.29 Mn |
| Dec 31, 2024 | -931,481.83 |
| Sep 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | -20.26 Mn |
| Mar 31, 2024 | -1.73 Mn |
| Dec 31, 2023 | 25.86 Mn |
| Sep 30, 2023 | -4.32 Mn |